Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle and adipose cell vesicles both protect neurons and reduce inflammation similarly.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

PLD is an effective and safer alternative for treating breast cancer.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.